Inflammation and cardiovascular status impact midazolam pharmacokinetics in critically ill children: An observational, prospective, controlled study
Abstract Altered physiology caused by critical illness may change midazolam pharmacokinetics and thereby result in adverse reactions and outcomes in this vulnerable patient population. This study set out to determine which critical illness‐related factors impact midazolam pharmacokinetics in childre...
Saved in:
Main Authors: | Bikalpa Neupane (Author), Hitesh Pandya (Author), Tej Pandya (Author), Rupert Austin (Author), Neil Spooner (Author), James Rudge (Author), Hussain Mulla (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?
by: Letao Li, et al.
Published: (2022) -
Pharmacokinetic-Pharmacodynamic Modeling of Midazolam in Pediatric Surgery
by: Carmen Flores-Pérez, et al.
Published: (2023) -
Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects
by: Isabelle Zenklusen, et al.
Published: (2024) -
Pharmacokinetics, Pharmacodynamics, and Side Effects of Midazolam: A Review and Case Example
by: Jens-Uwe Peter, et al.
Published: (2024) -
Cardiovascular Inflammation
by: Miao Wang, et al.
Published: (2013)